您的位置: 首页 > 农业专利 > 详情页

用於治療具有高殘疾狀況的復發-緩解型多發性硬化症(RRMS)的患者的拉喹莫德
专利权人:
Teva Pharmaceutical Industries Ltd.
发明人:
Volker KNAPPERTZ
申请号:
HK17105252.3
公开号:
HK1231413A
申请日:
2017.05.24
申请国别(地区):
HK
年份:
2017
代理人:
摘要:
This invention provides a method for treating or for reducing ambulatory deterioration in a human patient diagnosed to be afflicted with relapsing-remitting multiple sclerosis (RRMS) and having a high baseline disability score according to the Kurtzke Expanded Disability Status Scale (EDSS), comprising periodically administering to only the patient diagnosed with RRMS and having a high baseline disability score an amount of laquinimod effective to treat the patient or to reduce ambulatory deterioration. This invention further provides pharmaceutical compositions and packages comprising an effective amount of laquinimod for treating a human patient diagnosed to be afflicted with RRMS and having a high baseline disability score according to the EDSS.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充